IFNG and neoplasm: N1 neutrophils are key players in anti-tumor immunity, stimulating immune responses through the secretion of TNF-α, IL-12 and IFN-γ, exerting direct cytotoxicity via protease release, and limiting tumor progression by inhibiting angiogenesis [89–92].